Cleemput I - Search Results

1

Belgian population norms for the EQ-5D-5L, 2018.

Van Wilder L, Charafeddine R, Beutels P, Bruyndonckx R, Cleemput I, Demarest S, De Smedt D, Hens N, Scohy A, Speybroeck N, Van der Heyden J, Yokota RTC, Van Oyen H, Bilcke J, Devleesschauwer B. Van Wilder L, et al. Among authors: cleemput i. Qual Life Res. 2022 Feb;31(2):527-537. doi: 10.1007/s11136-021-02971-6. Epub 2021 Aug 18. Qual Life Res. 2022. PMID: 34406577 Free PMC article.

2

Gender and educational differences in the association between smoking and health-related quality of life in Belgium.

Charafeddine R, Demarest S, Cleemput I, Van Oyen H, Devleesschauwer B. Charafeddine R, et al. Among authors: cleemput i. Prev Med. 2017 Dec;105:280-286. doi: 10.1016/j.ypmed.2017.09.016. Epub 2017 Sep 28. Prev Med. 2017. PMID: 28964851 Free article. No abstract available.

3

A social preference valuations set for EQ-5D health states in Flanders, Belgium.

Cleemput I. Cleemput I. Eur J Health Econ. 2010 Apr;11(2):205-13. doi: 10.1007/s10198-009-0167-0. Epub 2009 Jul 7. Eur J Health Econ. 2010. PMID: 19582490

4

Re-scaling social preference data: implications for modelling.

Cleemput I, Kind P, Kesteloot K. Cleemput I, et al. Eur J Health Econ. 2004 Dec;5(4):290-8. doi: 10.1007/s10198-004-0242-5. Eur J Health Econ. 2004. PMID: 15759169

5

An EQ-5D-5L Value Set for Belgium.

Bouckaert N, Cleemput I, Devriese S, Gerkens S. Bouckaert N, et al. Among authors: cleemput i. Pharmacoecon Open. 2022 Nov;6(6):823-836. doi: 10.1007/s41669-022-00353-3. Epub 2022 Aug 4. Pharmacoecon Open. 2022. PMID: 35927410 Free PMC article.

6

The construct and concurrent validity of the EQ-5D in a renal transplant population.

Cleemput I, Kesteloot K, Moons P, Vanrenterghem Y, Van Hooff JP, Squifflet JP, De Geest S. Cleemput I, et al. Value Health. 2004 Jul-Aug;7(4):499-509. doi: 10.1111/j.1524-4733.2004.74013.x. Value Health. 2004. PMID: 15449642 Free article.

7

The determinants of defensive medicine practices in Belgium.

Vandersteegen T, Marneffe W, Cleemput I, Vandijck D, Vereeck L. Vandersteegen T, et al. Among authors: cleemput i. Health Econ Policy Law. 2017 Jul;12(3):363-386. doi: 10.1017/S174413311600030X. Epub 2016 Nov 22. Health Econ Policy Law. 2017. PMID: 27873571

8

Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests.

Cleemput I, van Wilder P, Huybrechts M, Vrijens F. Cleemput I, et al. Value Health. 2009 Jun;12(4):441-9. doi: 10.1111/j.1524-4733.2008.00469.x. Epub 2008 Nov 11. Value Health. 2009. PMID: 19900251 Free article.

9

Belgian guidelines for economic evaluations: second edition.

Thiry N, Neyt M, Van De Sande S, Cleemput I. Thiry N, et al. Among authors: cleemput i. Int J Technol Assess Health Care. 2014 Dec;30(6):601-7. doi: 10.1017/S0266462314000725. Int J Technol Assess Health Care. 2014. PMID: 25816826

10

Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders.

Cleemput I, Christiaens W, Kohn L, Léonard C, Daue F, Denis A. Cleemput I, et al. Value Health. 2015 Jun;18(4):477-83. doi: 10.1016/j.jval.2014.12.015. Epub 2015 Feb 18. Value Health. 2015. PMID: 26091602 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters